Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m - DRAP Registration MDIR-0002746
Access Pakistan DRAP registration details for Hyamira (Cross-linked Hyaluronic Acid Sodium Salt in prefilled syringe) 1.6% - 16mg/1ml and 32mg/2ml 2.0% - 20mg/1ml and 40mg/2m. Registered as MDIR-0002746 on 8/11/2021. Expires on 8/10/2026. Manufacturer: Schazoo SPL Consumer Healthcare at 71-B/C2, Gulberg-III, Lahore.
Free Database
Powered by Pure Global AI
Pakistan DRAP
Risk Class D
Hyamira (Cross-linked
Hyaluronic Acid
Sodium Salt in
prefilled syringe)
1.6% - 16mg/1ml and
32mg/2ml 2.0% -
20mg/1ml and
40mg/2m
DRAP Registration MDIR-0002746
Risk Class D
Pakistan
Registration Number
MDIR-0002746
Registration Date
8/11/2021
Expiry Date
8/10/2026
Action
ADD
Manufacturer
Manufacturing details from DRAP registration
Site
71-B/C2, Gulberg-III, Lahore
